Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mirati Therapeutics
(NQ:
MRTX
)
58.70
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mirati Therapeutics
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
Why Shares of Mirati Therapeutics Are Jumping Wednesday
August 09, 2023
The company replaced its CEO and reported strong revenue growth.
Via
The Motley Fool
Mirati Rockets 26% On A Bevy Of News In Cancer, A $300 Million Deal And Its CEO Exit
August 09, 2023
The company announced updates in cancer, a quarterly beat, a $300 million deal and its CEO departure.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 09, 2023
Via
Benzinga
8 Analysts Have This to Say About Mirati Therapeutics
July 14, 2023
Via
Benzinga
Expert Ratings for Mirati Therapeutics
June 16, 2023
Via
Benzinga
Analyst Expectations for Mirati Therapeutics's Future
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Via
Benzinga
Mirati Therapeutics: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Mirati Therapeutics: Here's What You Need To Know
December 14, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 21, 2023
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 21, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
During Tuesday's trading, 46 companies set new 52-week lows.
Via
Benzinga
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
June 02, 2023
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.
Via
Talk Markets
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 25, 2023
Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR.
Via
Benzinga
Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting
May 25, 2023
Via
Benzinga
Snowflake, American Eagle, Digital Turbine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 25, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 08, 2023
Via
Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...
Via
Benzinga
Why Shares of Zai Lab Soared This Week
January 05, 2023
A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.
Via
The Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
SKLZ Stock Alert: Will Skillz Shares Get Delisted?
December 22, 2022
Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange.
Via
InvestorPlace
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today?
December 22, 2022
Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday!
Via
InvestorPlace
Why Is ProQR (PRQR) Stock Up 83% Today?
December 22, 2022
ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY).
Via
InvestorPlace
Why Is Mirati Therapeutics (MRTX) Stock Up Today?
December 22, 2022
Mirati Therapeutics (MRTX) stock is rising on Thursday as investors react to a special designation from the FDA for adagrasib.
Via
InvestorPlace
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
December 15, 2022
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Tesla To $235? Here Are 10 Other Price Target Changes For Wednesday
December 14, 2022
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $305 to $235. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 0.4% to $160.35 in pre-market...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.